| Paul Jon Apostolides, MD | |
|
6 Greenwich Office Park, Greenwich, CT 06831-5151 | |
| (203) 869-1145 | |
| (203) 618-1721 |
| Full Name | Paul Jon Apostolides |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 38 Years |
| Location | 6 Greenwich Office Park, Greenwich, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265403927 | NPI | - | NPPES |
| 200033414 | Other | CT | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 036771 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Greenwich Hospital Association - | Greenwich, CT | Hospital |
| Stamford Hospital | Stamford, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopaedic And Neurosurgery Specialists, Pllc | 5294628947 | 208 |
| Orthopaedic And Neurosurgery Specialists, Pllc | 5294628947 | 208 |
News Archive
A group of researchers at the Technical University of Denmark and the University of Copenhagen have developed models of neural networks that make it possible to simulate how the body protects itself from disease and predict the immune system's access codes.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
In this study, researchers posing as parents sought specialty care for children in Cook County, Ill., to examine access opportunities for families on Medicaid. They found a major disparity between children with public insurance versus private insurance - 66 percent of the callers saying the children were insured by Medicaid were denied an appointment, compared to 11 percent with a private plan.
Clinicians and researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present new findings from eight abstracts at the International Federation of Head and Neck Oncologic Societies World Congress being held July 26 - July 30 in New York.
NovoStent Corporation, a privately held medical device company, today announced the 6-month follow-up results of the company's European clinical trial evaluating the use of its SAMBA Stent and Delivery System in the treatment of superficial femoral and popliteal artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of increased vessel coverage, strength and flexibility.
› Verified 9 days ago
| Entity Name | Greenwich Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609846088 PECOS PAC ID: 3678476710 Enrollment ID: O20040128000288 |
News Archive
A group of researchers at the Technical University of Denmark and the University of Copenhagen have developed models of neural networks that make it possible to simulate how the body protects itself from disease and predict the immune system's access codes.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
In this study, researchers posing as parents sought specialty care for children in Cook County, Ill., to examine access opportunities for families on Medicaid. They found a major disparity between children with public insurance versus private insurance - 66 percent of the callers saying the children were insured by Medicaid were denied an appointment, compared to 11 percent with a private plan.
Clinicians and researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present new findings from eight abstracts at the International Federation of Head and Neck Oncologic Societies World Congress being held July 26 - July 30 in New York.
NovoStent Corporation, a privately held medical device company, today announced the 6-month follow-up results of the company's European clinical trial evaluating the use of its SAMBA Stent and Delivery System in the treatment of superficial femoral and popliteal artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of increased vessel coverage, strength and flexibility.
› Verified 9 days ago
| Entity Name | Orthopaedic & Neurosurgery Specialists, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033318720 PECOS PAC ID: 5294628947 Enrollment ID: O20040205000859 |
News Archive
A group of researchers at the Technical University of Denmark and the University of Copenhagen have developed models of neural networks that make it possible to simulate how the body protects itself from disease and predict the immune system's access codes.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
In this study, researchers posing as parents sought specialty care for children in Cook County, Ill., to examine access opportunities for families on Medicaid. They found a major disparity between children with public insurance versus private insurance - 66 percent of the callers saying the children were insured by Medicaid were denied an appointment, compared to 11 percent with a private plan.
Clinicians and researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present new findings from eight abstracts at the International Federation of Head and Neck Oncologic Societies World Congress being held July 26 - July 30 in New York.
NovoStent Corporation, a privately held medical device company, today announced the 6-month follow-up results of the company's European clinical trial evaluating the use of its SAMBA Stent and Delivery System in the treatment of superficial femoral and popliteal artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of increased vessel coverage, strength and flexibility.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul Jon Apostolides, MD 6 Greenwich Office Park, Greenwich, CT 06831-5151 Ph: (203) 869-1145 | Paul Jon Apostolides, MD 6 Greenwich Office Park, Greenwich, CT 06831-5151 Ph: (203) 869-1145 |
News Archive
A group of researchers at the Technical University of Denmark and the University of Copenhagen have developed models of neural networks that make it possible to simulate how the body protects itself from disease and predict the immune system's access codes.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
In this study, researchers posing as parents sought specialty care for children in Cook County, Ill., to examine access opportunities for families on Medicaid. They found a major disparity between children with public insurance versus private insurance - 66 percent of the callers saying the children were insured by Medicaid were denied an appointment, compared to 11 percent with a private plan.
Clinicians and researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present new findings from eight abstracts at the International Federation of Head and Neck Oncologic Societies World Congress being held July 26 - July 30 in New York.
NovoStent Corporation, a privately held medical device company, today announced the 6-month follow-up results of the company's European clinical trial evaluating the use of its SAMBA Stent and Delivery System in the treatment of superficial femoral and popliteal artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of increased vessel coverage, strength and flexibility.
› Verified 9 days ago
Andrea F Douglas, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 25 Valley Dr, Greenwich, CT 06831 Phone: 203-661-3333 Fax: 203-661-5610 | |
Mark H Camel, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6 Greenwich Office Park, Greenwich, CT 06831 Phone: 203-869-1145 Fax: 203-618-1721 | |
John G Strugar, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 15 Valley Dr, Greenwich, CT 06831 Phone: 203-785-2807 Fax: 203-863-4496 | |
Zion Zibly, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 15 Valley Dr Ste 201, Greenwich, CT 06831 Phone: 203-737-2096 | |
Scott L Simon, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6 Greenwich Office Park, Greenwich, CT 06831 Phone: 203-869-1145 Fax: 203-618-1721 | |
Amory J Fiore, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6 Greenwich Office Park, Greenwich, CT 06831 Phone: 203-869-1145 Fax: 203-618-1721 |